XML 51 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes [Abstract]  
Schedule of Federal and State Income Tax Expense Federal and State income tax expense is as follows:
   For the Years Ended
December 31,
 
   2023   2022 
Current        
Federal  $
-
   $
-
 
State   
-
    
-
 
Total current   
-
    
-
 
Deferred          
Federal   (9,627)   (7,954)
State   (4,124)   (1,068)
Total deferred   (13,751)   (9,022)
Change in valuation allowance   13,751    9,022 
Total income tax expense (benefit)  $
-
   $
-
 
Schedule of Deferred Tax Assets and Liabilities The tax effects of temporary differences that give rise to significant portions of the deferred tax assets are as follows:
   As of
December 31,
 
   2023   2022 
Deferred tax assets:        
Net operating loss carry forwards  $30,731   $26,768 
Capitalized research and development   9,611    3,418 
Stock option expense   4,464    2,477 
Research and development credits   4,824    3,710 
Operating lease liability   1,485    1,481 
RSU expense   2,723    2,199 
Other   467    408 
Total deferred tax assets   54,305    40,461 
Valuation allowance   (52,734)   (38,983)
Deferred tax assets, net of valuation allowance   1,571    1,478 
Deferred tax liabilities:          
Operating right-of-use asset   (1,430)   (1,456)
Other   (141)   (22)
Total deferred tax liabilities   (1,571)   (1,478)
Deferred tax assets, net of valuation allowance and deferred tax liabilities  $
-
   $
-
 
Schedule of Federal Income Tax to Income Before Provision for Income Taxes A reconciliation of the provision for income taxes with the amounts computed by applying the statutory Federal income tax to income before provision for income taxes is as follows:
   For the Years Ended
December 31,
 
   2023   2022 
U.S. federal statutory rate   (21.0)%   (21.0)%
State taxes, net of federal benefit   (7.8)%   (2.2)%
State rate change   (4.0)%   
-
%
Research and development credits   (2.4)%   (3.3)%
True-up to prior years return   2.2%   (0.7)%
Stock-based compensation   (1.3)%   0.1%
Other   0.4%   (0.3)%
Goodwill impairment   
-
%   10.4%
Change in valuation allowance   33.9%   17.0%
Effective tax rate   
-
%   
-
%